Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 12, 2009, Pages 1487-1490

  Potthoff, A ^a   Berg, T ^b   Wedemeyer, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Universittsklinik Berlin ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ANTIVIRAL THERAPY; ARTICLE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LONG TERM CARE; MIXED INFECTION; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; COMORBIDITY; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; POLYETHYLENE GLYCOLS; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 72449191348     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903329585     Document Type: Article

References (8)

1. R Jardi, F Rodriguez, M Buti, X Costa, M Cotrina, R Galimany, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001;34:404-10.
2. J Amin, MG Law,M Bartlett, JM Kaldor, GJ Dore. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006;368: 938-45.
3. G Raimondo, C Saitta. Treatment of the hepatitis B virus and hepatitis C virus co-infection: still a challenge for the hepatologist. J Hepatol 2008;49:677-9.
4. G Raimondo, MR Brunetto, P Pontisso, A Smedile, AM Maina, C Saitta, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/ hepatitis C virus-coinfected patients. Hepatology 2006;43:100-7.
5. European Association For The Study of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-42.
6. M Cornberg, U Protzer, MM Dollinger, J Petersen, H Wedemeyer, T Berg, et al. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. Z Gastroenterol 2007;45:1281-328.
7. A Potthoff, H Wedemeyer, WO Boecher, T Berg, S Zeuzem, J Arnold, et al. The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J Hepatol 2008;49:688-94.
8. CJ Liu, WL Chuang, CM Lee, ML Yu, SN Lu, SS Wu, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009;136:496-504 e3.